Mulligan, G.

expression relapse relapse cases presence myeloma cancer testi antigen patient survival frequency prognostic analysis study table cta genes cta expression trial magea cluster probe ssx 1 magec testis-restricted tissue hovon -65/gmmg trial cancer testis antigens immunotherapy hovon progression magea 9 tissue restriction blood sample value target probe sets gene expression cdca 1 treatment restriction -65/gmmg plasma haematologica plasma cell samples plasma cells prognostic value magec 1 ctag 2 relapse mm cases /brain magea 6 prognostic markers mm cases difference apex trial factor <0.0001 presence frequency relapse patients figure testis-selective cluster analysis mageb line presence bortezomib myeloma patients multivariate analysis marker tumor myeloma cells result prognostic factor classification ct database correlation protein pattern therapy absence